Tobin Bernard 4
4 · MYRIAD GENETICS INC · Filed Sep 26, 2019
Insider Transaction Report
Form 4
Tobin Bernard
President Crescendo BioScience
Transactions
- Disposition to Issuer
Common Stock
2019-09-25$29.93/sh−4,958$148,393→ 171,743 total - Award
Common Stock
2019-09-25+35,000→ 181,040 total - Disposition to Issuer
Common Stock
2019-09-25$29.93/sh−4,339$129,866→ 176,701 total
Footnotes (2)
- [F1]Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023.
- [F2]Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.